Back to resultsComparison Of Effects of MRP Vs NDT For Balance and Gait in Chronic Ischemic Stroke Patients RCT
Primary Purpose
Stroke
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Motor Relearning Program (MRP)
Neuro Development Treatment (NDT)
Sponsored by
About this trial
This is an interventional health services research trial for Stroke
Eligibility Criteria
Inclusion Criteria: Chronic ischemic stroke Patients more than 6 months. (55) Patient with good cognitive status minimum 20 or greater out of 30 in Mini mental state examinations.(56) Age between 45-65 years.(57) Patient with limb spasticity equal to 2 or less than 2 on Modified Ashworth scale.(56) Both male and female patients.(58) Exclusion Criteria: History of neurologic disease(59, 60) History of lower limb fracture.(61) History of spinal cord fracture.(61) Patient with skin discoloration, skin ulcers and skin allergy.(62) Patients with a history of the recurrent stroke. (63) Patients with any peripheral vascular disease.(60)
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Motor Relearning Program (MRP)
Neuro Development Treatment (NDT)
Arm Description
Outcomes
Primary Outcome Measures
Effects of Motor Relearning Program Techinique, Neuro Development Treatment Techinique
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05810844
Brief Title
Comparison Of Effects of MRP Vs NDT For Balance and Gait in Chronic Ischemic Stroke Patients RCT
Official Title
Comparison Of Effects of Motor Relearning Program (MRP) Versus Neuro Development Treatment (NDT) For Balance and Gait in Chronic Ischemic Stroke Patients: A Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
April 1, 2023 (Anticipated)
Primary Completion Date
June 1, 2023 (Anticipated)
Study Completion Date
August 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Superior University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
To determine the comparison between effects of Motor Relearning Program (MRP) and Neuro-Development Treatment (NDT) on balance and gait in chronic ischemic stroke patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Motor Relearning Program (MRP)
Arm Type
Experimental
Arm Title
Neuro Development Treatment (NDT)
Arm Type
Experimental
Intervention Type
Diagnostic Test
Intervention Name(s)
Motor Relearning Program (MRP)
Intervention Description
MRP technique with a conventional physiotherapy treatment. Conventional physiotherapy treatment will help to reduce the functional impairments in chronic ischemic stroke
Intervention Type
Diagnostic Test
Intervention Name(s)
Neuro Development Treatment (NDT)
Intervention Description
Neuro-Development Treatment NDT as well as conventional treatment. Conventional physiotherapy treatment will help to reduce the functional impairments in chronic ischemic stroke patients
Primary Outcome Measure Information:
Title
Effects of Motor Relearning Program Techinique, Neuro Development Treatment Techinique
Time Frame
6 Months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Chronic ischemic stroke Patients more than 6 months. (55)
Patient with good cognitive status minimum 20 or greater out of 30 in Mini mental state examinations.(56)
Age between 45-65 years.(57)
Patient with limb spasticity equal to 2 or less than 2 on Modified Ashworth scale.(56)
Both male and female patients.(58)
Exclusion Criteria:
History of neurologic disease(59, 60)
History of lower limb fracture.(61)
History of spinal cord fracture.(61)
Patient with skin discoloration, skin ulcers and skin allergy.(62)
Patients with a history of the recurrent stroke. (63)
Patients with any peripheral vascular disease.(60)
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Comparison Of Effects of MRP Vs NDT For Balance and Gait in Chronic Ischemic Stroke Patients RCT
We'll reach out to this number within 24 hrs